Regulation of glial cell line-derived neurotrophic factor release from rat C6 glioblastoma cells

Journal of Neurochemistry

Volumn 70, Issue 2, 1998, Pages 531-539

  Verity, A Neil ^a   Wyatt, T L ^a   Hajos, B ^a   Eglen, R M ^a   Baecker, P A ^a   Johnson, R M ^a  

^a Center for Biological Research   (United States)

Author keywords

C6 glioblastoma; ELISA; Glial cell line derived neurotrophic factor; Neurotrophin; Secretion

Indexed keywords

BUCLADESINE; CALCIMYCIN; CYCLIC AMP; CYTOKINE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FORSKOLIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; OKADAIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GLIOBLASTOMA; NEUROMODULATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS REGULATION; RAT; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0031914582     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70020531.x     Document Type: Article

References (60)

1. Amano S., Hazama F., Kawai J., and Sasahara M. (1990) Increased 5′-nucleotidase activity induced by dibutyryl cyclic AMP treatment of cultured glial cells. Brain Res. 506, 254-258.
2. Auphan N., DiDonato J. A., Rosette C., Helmberg A., and Karin M. (1995) Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270, 286-290.
3. Baldwin A. S. (1996) The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-681.
4. Bansal R., Kumar M., Murray K., Morrison R. S., and Pfeiffer S. E. (1996) Regulation of FGF receptors in the oligodendrocyte lineage. Mol. Cell. Neurosci. 7, 263-275.
5. Beck K. D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R. A., Rosenthal A., and Hefti F. (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373, 339-341.
6. Bishop J. F., Wang W., Mueller G. P., and Mouradian M. M. (1995) Effects of elevated intracellular calcium on GDNF expression. Soc. Neurosci. Abstr. 21, 1046.
7. Bowenkamp K. E., Hoffman A. F., Gerhardt G. A., Henry M. A., Biddle P. T., Hoffer B. J., and Granholm A. C. (1995) Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J. Comp. Neurol. 355, 479-489.
8. 6 glioma cells. J. Neurochem. 64, 818-824.
9. Choi-Lundberg D. L. and Bohn M. C. (1995) Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Dev. Brain Res. 85, 80-88.
10. Choi-Lundberg D. L., Lin Q., Chang Y., Chiang Y. L., Hay C. M., Mohajeri H., Davidson B. L., and Bohn M. C. (1997) Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275, 838-841.
11. Durante W., Kroll M. H., Christodoulides N., Peyton K. J., and Schafer A. I. (1997) Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ. Res. 80, 557-564.
12. Gash D. M., Zhang Z., Ovadia A., Cass W. A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P. A., Collins F., Hoffer B. J., and Gerhardt G. A. (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380, 252-255.
13. Givol D. and Yayon A. (1992) Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J. 6, 3362-3369.
14. Granholm A. C. E., Srivastava N., Mott J. L., Henry M., Westphal H., Pichel J. G., Shen L. Y., and Hoffer B. J. (1997) Morphological alterations in the peripheral and central nervous systems of mice lacking glial cell line-derived neurotrophic factor (GDNF). J. Neurosci. 17, 1168-1178.
15. Henderson C. E., Phillips H. S., Pollock R. A., Davies A. M., Lemeulle C., Armanini M., Simmons L., Moffet B., Vandlen R. A., and Simmons L. (1994) GDNF: a potent survival factor for motorneurons present in peripheral nerve and muscle. Science 266, 1062-1064.
16. Ho A., Gore A. C., Weickert C. S., and Blum M. (1995) Glutamate regulation of GDNF gene expression in the striatum and primary striatal astrocytes. Neuroreport 6, 1454-1458.
17. Humpel C., Hoffer B., Stromberg I., Bektesh S., Collins F., and Olson L. (1994) Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger RNA in response to kainate-induced excitation. Neuroscience 59, 791-795.
18. Johnson D. E. and Williams L. T. (1993) Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60, 1-41.
19. Kearns C. M. and Gash D. M. (1995) GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672, 104-111.
20. Lee K., Kentroti S., Billie H., Bruce C., and Vernadakis A. (1992) Comparative biochemical, morphological and immunocytochemical studies between C-6 glial cells of early and late passages and advanced passages of glial cells derived from aged mouse cerebral hemispheres. Glia 6, 245-257.
21. Lin L. H., Doherty D. H., Lile J. D., Bektesh S., and Collins F. (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132.
22. Lindner M. D., Winn S. R., Baetge E. E., Hammang J. P., Gentile F. T., Doherty E., McDermott P. E., Frydel B., Ulman M. D., and Schallert T. (1995) Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms. Exp. Neurol. 132, 62-76.
23. Martin D., Miller G., Rosendahl M., and Russell D. A. (1995) Potent inhibitory effects of glial cell line-derived neurotrophic factor against kainic acid mediated seizures in the rat. Brain Res. 683, 172-178.
24. McNeeley P. A., Baecker P. A., Jones N. L., Emmett C. J., Eglen R. M., Wong E. H. F., and Johnson R. M. (1995) Interleukin-1β induces nerve growth factor release and gene expression in human glioblastoma cells. Proc. West. Pharmacol. Soc. 38, 63-66.
25. Miyake A., Hattori Y., Ohta M., and Itoh N. (1996) Rat oligodendrocytes and astrocytes preferentially express fibroblast growth factor receptor-2 and -3 mRNAs. J. Neurosci. Res. 45, 534-541.
26. Miyamoto M., Naruo K., Seko C., Matsumoto S., Kondo T., and Kurokawa T. (1993) Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. Mol. Cell. Biol. 13, 4251-4259.
27. Moore M. W., Klein R. D., Farinas I., Sauer H., Armanini M., Phillips H., Reichardt L. F., Ryan A. M., Carver-Moore K., and Rosenthal A. (1996) Renal and neuronal abnormalities in mice lacking GDNF. Nature 382, 76-79.
28. Moretto M., Lopez F. J. J., and Negro-Vilar A. (1993) Nitric oxide regulates luteinizing hormone-releasing hormone secretion. Endocrinology 133, 2399-2402.
29. Moynagh P. N., Williams D. C., and O'Neill L. A. (1993) Interleukin-1 activates transcription factor NF kappa B in glial cells. Biochem. J. 294, 343-347.
30. Naruo K., Seko C., Kuroshima K., Matsutani E., Sasada R., Kondo T., and Kurokawa T. (1993) Novel secretory heparin-binding factors from human glioma cells (glia-activating factors) involved in glial cell growth. J. Biol. Chem. 268, 2857-2864.
31. Naveilhan P., Neveu I., Wion D., and Brachet P. (1996) 1,25-Dihydroxyvitamin D-3, an inducer of glial cell line-derived neurotrophic factor. Neuroreport 7, 2171-2175.
32. Neveu I., Naveilhan P., Jehan F., Baudet C., Wion D., De Luca H. F., and Brachet P. (1994) 1,25-Dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Mol. Brain Res. 24, 70-76.
33. Nishiya T., Uehara T., and Nomura Y. (1995) Herbimycin A suppresses NF-kappa B activation and tyrosine phosphorylation of JAK2 and the subsequent induction of nitric oxide synthase in C6 glioma cells. FEBS Lett. 371, 333-336.
34. Nosrat C. A., Tomac A., Lindqvist E., Lindskog S., Humpel C., Stromberg I., Ebendal T., Hoffer B. J., and Olson L. (1996) Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous system. Cell Tissue Res. 286, 191-207.
35. Pichel J. G., Shen L., Sheng H. Z., Granholm A., Drago J., Grinberg A., Lee E. J., Huang S. P., Saarma M., Hoffer B. J., Sariola H., and Westphal H. (1996) Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382, 73-76.
36. Powell P. P. and Klagsbrun M. (1993) Regulation of basic fibroblastic growth factor mRNA expression in rat C6 glioma cells. Exp. Cell Res. 209, 224-230.
37. Sanchez P. P., Silos-Santiago I., Frisen J., He B., Lira S. A., and Barbacid M. (1996) Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382, 70-73.
38. Santos-Ocampo S., Colvin J. S., Chellaiah A., and Ornitz D. M. (1996) Expression and biological activity of mouse fibroblast growth factor-9. J. Biol. Chem. 271, 1726-1731.
39. Sauer H., Rosenblad C., and Bjorklund A. (1995) Glial cell line-derived neurotrophic factor but not transforming factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. Natl. Acad. Sci. USA 92, 8935-8939.
40. Schaar D. G., Sieber B., Dreyfus C. F., and Black I. B. (1993) Regional and cell-specific expression of GDNF in rat brain. Exp. Neural. 124, 368-371.
41. Schaar D. G., Sieber B., Sherwood A. C., Dean D., Mendoza G., Ramakrishnan L., Dreyfus C. F., and Black I. B. (1994) Multiple astrocyte transcripts encode nigral trophic factors in rat and human. Exp. Neurol. 130, 387-393.
42. Scheinmann R. I., Cogswell P. C., Lofquist A. K., and Baldwin A. S. (1995) Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270, 283-286.
43. Schereck R., Reiber P., and Bauerle P. A. (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10, 2247-2255.
44. fyn tyrosine kinases in human lymphocytes. Blood 82, 1212-1220.
45. Schindelhauer D., Schuffenhauer S., Gasser T., Steinkasserer A., and Meitinger T. (1995) The gene coding for glial cell line derived neurotrophic factor (GDNF) maps to chromosome 5p12-p13.1. Genomics 28, 607-609.
46. Schmidt H. H. H. W., Lohmann S. M., and Walter U. (1993) The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim. Biophys. Acta 1178, 153-175.
47. 67) and increases the expression of an astroglial marker (GFAP) in C6 cells. J. Neurochem. 63, 1218-1225.
48. Springer J. E., Mu X., Bergmann L. W., and Trojanowski J. Q. (1994) Expression of GDNF mRNA in rat and human nervous tissue. Exp. Neurol. 127, 167-170.
49. Springer J. E., Seeburger J. L., He J., Gabrea A., Blankenhorn E. P., and Bergman L. W. (1995) cDNA sequence and differential mRNA regulation of two forms of glial cell line-derived neurotrophic factor in Schwann cells and rat skeletal muscle. Exp. Neurol. 131, 47-52.
50. Stachowiak M. K., Maher P. A., Joy A., Mordechai E., and Stachowiak E. K. (1996) Nuclear localization of functional FGF receptor 1 in human astrocytes suggests a novel mechanism for growth factor action. Mol. Brain Res. 38, 161-165.
51. Stromberg I., Bjorklund A., Johansson M., Tomac A., Collins F., Olson L., Hoffer B., and Humpel C. (1993) Glial cell line-derived neurotrophic factor is expressed in the developing but not the adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol. 124, 401-412.
52. Suter-Crazzolara C. and Unsicker K. (1994) GDNF is expressed in two forms in many tissues outside the CNS. Neuroreport 5, 2486-2488.
53. Suter-Crazzolara C. and Unsicker K. (1996) GDNF mRNA levels are induced by FGF-2 in rat C6 glioblastoma cells. Mol. Brain Res. 41, 175-182.
54. Tagashira S., Ozaki K., Ohta M., and Itoh N. (1995) Localization of fibroblast growth factor-9 mRNA in the rat brain. Mol. Brain Res. 30, 233-241.
55. Takahashi K., Hara E., Suzuki H., Sasano H., and Shibahara S. (1996) Expression of heme oxygenase isozyme mRNAs in the human brain and induction of heme oxygenase-1 by nitric oxide donors. J. Neurochem. 67, 482-489.
56. Tomac A., Lindqvist E., Lin L. F., Ogren S. O., Young D., Hoffer B. J., and Olson L. (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373, 335-339.
57. Trupp M., Ryden M., Jornvall H., Funakoshi H., Timmusk T., Arenas E., and Ibanez C. F. (1995) Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J. Cell Biol. 130, 137-148.
58. Woodbury D., Schaar D. G., Ramakrishnan L., and Black I. B. (1997) A novel promoter allows regulated and constitutive expression of the human GDNF gene. Soc. Neurosci. Abstr. 23, 90.
59. Yasin S., Costa A., Trainer P., Windle R., Forsling M. L., and Grossman A. (1993) Nitric oxide modulates the release of vasopressin from rat hypothalamic explants. Endocrinology 133, 1466-1469.
60. Zurn A. D., Baetge E. E., Hammang J. P., Tan S. A., and Aebischer P. (1994) Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic factor for motorneurones. Neuroreport 6, 113-118.